Gregers R. Andersen

What is he best known for?

The fields of study he is best known for:

• Enzyme
• Gene
• DNA

Gregers R. Andersen mainly focuses on Biochemistry, Elongation factor, Ribosome, Binding site and Protein biosynthesis. His research brings together the fields of Biophysics and Biochemistry. The study incorporates disciplines such as Prokaryotic translation, Transfer RNA, EF-Tu, Antifungal drug and Cell biology in addition to Elongation factor.

His Ribosome research is multidisciplinary, relying on both Protein structure, EEF2 and Diphthamide. As a part of the same scientific study, he usually deals with the Binding site, concentrating on Stereochemistry and frequently concerns with Crystallography, Crystal structure and Complement inhibitor. Gregers R. Andersen usually deals with Protein biosynthesis and limits it to topics linked to Translation and Function, Cytoplasm, Nuclear export signal and Molecular biology.

His most cited work include:

• Domain movements of elongation factor eEF2 and the eukaryotic 80S ribosome facilitate tRNA translocation (332 citations)
• Structure of the Exon Junction Core Complex with a Trapped DEAD-Box ATPase Bound to RNA (317 citations)
• Bacterial Polypeptide Release Factor Rf2 is Structurally Distinct from Eukaryotic Erf1. (177 citations)

What are the main themes of his work throughout his whole career to date?

Gregers R. Andersen mostly deals with Biochemistry, Cell biology, Complement system, Biophysics and Crystallography. His is doing research in Elongation factor, Protein structure, RNA, Receptor and Binding site, both of which are found in Biochemistry. Within one scientific family, Gregers R. Andersen focuses on topics pertaining to Translation under Elongation factor, and may sometimes address concerns connected to Protein biosynthesis and Nucleotide.

In Cell biology, Gregers R. Andersen works on issues like Innate immune system, which are connected to C5-convertase. His work deals with themes such as Structural biology and Complement, which intersect with Complement system. His study in Ribosome is interdisciplinary in nature, drawing from both Transfer RNA and Diphthamide.

He most often published in these fields:

• Biochemistry (31.52%)
• Cell biology (26.06%)
• Complement system (22.42%)

What were the highlights of his more recent work (between 2017-2021)?

• Complement system (22.42%)
• Cell biology (26.06%)
• Alternative complement pathway (10.91%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Complement system, Cell biology, Alternative complement pathway, Properdin and Classical complement pathway. He has researched Complement system in several fields, including Paroxysmal nocturnal hemoglobinuria, Innate immune system, Binding site and Complement. His Cell biology research integrates issues from Receptor, Antibody and Complement receptor.

His Alternative complement pathway research is multidisciplinary, relying on both Inflammation, Cleavage and Flow cytometry. His Properdin research incorporates elements of Biophysics, Docking and Collectin. His study on Protease is covered under Biochemistry.

Between 2017 and 2021, his most popular works were:

• Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts Fc epsilon RI interaction. (45 citations)
• Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System. (22 citations)
• A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement. (19 citations)